Asian Annals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Guy J Fradet
Samuel V Lichtenstein
Robert T Miyagishima
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jamieson, W. E.
Right arrow Articles by Miyagishima, R. T
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jamieson, W. E.
Right arrow Articles by Miyagishima, R. T
Asian Cardiovasc Thorac Ann 2000;8:121-126
© 2000 Asia Publishing EXchange Pte Ltd


ORIGINAL CONTRIBUTION

Bioprostheses and Mechanical Prostheses Predictors of Performance

WR Eric Jamieson, MD, Eva Germann, MSc, Guy J Fradet, MD, Samuel V Lichtenstein, MD, Robert T Miyagishima, MD

Department of Surgery
Faculty of Medicine
University of British Columbia
Vancouver, British Columbia, Canada
For reprint information contact: WR Eric Jamieson, MD Tel: 1 604 806 8383 Fax: 1 604 806 8384 St. Paul's Hospital, 1081 Burrard St., 331–332 Burrard Building, Vancouver, BC V6Z 1Y6, Canada.
From 1975 to 1995, 4200 patients had bioprosthetic valve replacements (2240 aortic, 1607 mitral, 353 multiple) and 2038 had mechanical valve replacements (747 aortic, 928 mitral, 363 multiple). Freedom from major thromboembolism or both major thromboembolism and hemorrhage for aortic and mitral valve replacement at 15 years was significantly greater for bioprostheses than mechanical prostheses. Freedom from valve-related mortality and reoperation for both aortic and mitral valve replacements was the same for bioprostheses and mechanical prostheses. Advancing age increased overall mortality (all positions), valve-related mortality (aortic, mitral), major thromboembolism (aortic), thromboembolism and hemorrhage (aortic, mitral) but decreased reoperation (all positions). Coronary artery bypass grafting increased overall mortality (aortic, mitral) but not valve-related mortality, and it decreased reoperation rate (aortic, mitral). Overall mortality was not influenced by valve type in aortic or multiple valve replacement but it was decreased by bioprostheses in mitral valve replacement. Valve type did not influence valve-related mortality (all positions). Mechanical valves decreased reoperation only for aortic valve replacement but they increased major thromboembolism with and without hemorrhage for both aortic and mitral replacements. There is support for bioprostheses in aortic valve replacement and mechanical prostheses in mitral valve replacement but for neither in multiple valve replacements.




This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
K. Prasongsukarn, W. E. Jamieson, E. Germann, F. Chan, and S. V Lichtenstein
Aortic and Mitral Prosthetic Valve Replacement in Age Groups 61 65 & 66 70 Years
Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 127 - 133.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by SAGE Publications